A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma
Open Access
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (11), 1575-1580
- https://doi.org/10.1023/a:1013129315036
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Standard Chemotherapy for Gastric Carcinoma: Is It a Myth?Journal of Clinical Oncology, 2000
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialBritish Journal of Cancer, 1999
- Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric CancerJournal of Clinical Oncology, 1999
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.Journal of Clinical Oncology, 1996
- Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT)Investigational New Drugs, 1995
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancerAmerican Journal of Clinical Oncology, 1983
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980
- Integration of chemotherapy into combined modality treatment of solid tumors: III. Gastric cancerCancer Treatment Reviews, 1974